title: [Nausea and vomiting during treatment with cytostatics].
abstract: Combination chemotherapy can often induce severe side effects such as nausea and vomiting. These unpleasant symptoms can delay or stop potentially curative therapy. Metoklopramid has traditionally been the most potent antiemetic drug, either given in doses of 20-50 mg or as high doses combined with dexamethazone and diazepam. The authors review antiemetic regimens and make a recommendation on antiemetic treatment.
authors.affiliation: Onkologisk avdeling, Det Norske Radiumhospital, Oslo.
authors.forename: S
authors.initials: S
authors.lastname: Kaasa
authors.forename: O
authors.initials: O
authors.lastname: Mella
authors.forename: A
authors.initials: A
authors.lastname: Kvikstad
mesh_terms: D000932:Antiemetics / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D006801:Humans; D008787:Metoclopramide / Q000008:administration & dosage; D009325:Nausea / Q000139:chemically induced* / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced* / Q000188:drug therapy
chemical_list: D000932:Antiemetics; D000970:Antineoplastic Agents; D008787:Metoclopramide
vernacular_title: Kvalme og oppkast ved cytostatikabehandling.